Abstract:Background Tumor-associated macrophages (TAMs) play an important role in growth, progression and metastasis of tumors. In non-small cell lung cancer (NSCLC), TAMs' anti-tumor or pro-tumor role is not determined. Macrophages are polarized into M1 (with anti-tumor function) and M2 (with pro-tumor function) forms. This study was conducted to determine whether the M1 and M2 macrophage densities in NSCLC are associated with patient's survival time. Methods Fifty patients with an average of 1-year survival (short survival group) and 50 patients with an average of 5-year survival (long survival group) were included in this retrospective study. Paraffin-embedded NSCLC specimens and their clinicopathological data including up to 8-year follow-up information were used. Immunohistochemical double-staining of CD68/HLA-DR (markers for M1 macrophages) and CD68/CD163 (markers for M2 macrophages) was performed and evaluated in a blinded fashion. The M1 and M2 macrophage densities in the tumor islets, stroma, or islets and stroma were determined using computer-aided microscopy. Correlation of the macrophage densities and patient's survival time was analyzed using the Statistical Package for the Social Sciences. Results Approximately 70% of TAMs were M2 macrophages and the remaining 30% were M1 macrophages in NSCLC. The M2 macrophage densities (approximately 78 to 113 per mm 2 ) in the tumor islets, stroma, or islets and stroma were not significantly different between the long survival and short survival groups. The M1 macrophage densities in the tumor islets (approximately 70/mm 2 ) and stroma (approximately 34/mm 2 ) of the long survival group were significantly higher than the M1 macrophage densities in the tumor islets (approximately 7/mm 2 ) and stroma (13/mm 2 ) of the short survival group (P < 0.001 and P < 0.05, respectively). The M2 macrophage densities were not associated with patient's survival time. The M1 macrophage densities in the tumor islets, stroma, or islets and stroma were positively associated with patient's survival time in a univariate analysis (P < 0.01 or 0.001). In a multivariate Cox proportional hazards analysis, the M1 macrophage density in the tumor islets was an independent predictor of patient's survival time. Conclusions The M1 macrophage density in the tumor islets is an independent predictor of survival time in NSCLC patients.

A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.

Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

Prognostic Significance of Tumor-Associated Macrophages in Ovarian Cancer: A Meta-Analysis.

Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis

Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.

High MUC2 Expression in Ovarian Cancer is Inversely Associated with the M1/M2 Ratio of Tumor-Associated Macrophages and Patient Survival Time

[Prognostic Significance of Tumor-Associated Macrophage Infiltration in Advanced Epithelial Ovarian Carcinoma].

Mixed-phenotype of tumor-associated macrophages in the peritoneal environment of ovarian cancer and its TLR expression characteristics

Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature

Tumor-Associated Macrophages (tams): A Critical Activator in Ovarian Cancer Metastasis

The M1 Form of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer is Positively Associated with Survival Time

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

Ott_a_216355 8687..8699

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy

Ratio of M2 Tumor-Associated Macrophages As a Better Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.

Prognostic Value Of Tumor-Associated Macrophages In Clear Cell Renal Cell Carcinoma: A Systematic Review And Meta-Analysis

Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis.

Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro

Prognostic Impact of Tumor-Associated Macrophage Infiltration in Non-Small Cell Lung Cancer: A Systemic Review and Meta-Analysis

Clinicopathologic and Prognostic Significance of Tumor-Associated Macrophages in Cervical Cancer: a Systematic Review and Meta-Analysis.